Condition: Prostate Cancer · Sponsor: Memorial Sloan Kettering Cancer Center
In this study the investigators will find out whether the use of a new type of boost approach called irreversible electroporation (IRE) is as effective as the standard boost approach of radiation therapy for participants with intermediate-risk prostate cancer receiving standard stereotactic body radiotherapy (SBRT).
This description comes directly from the study's public registry record.
Himanshu Nagar, MD · 212-639-6478 · nagarh1@mskcc.org
Jonathan Fainberg, MD, MPH · 646-422-4894 · fainberj@mskcc.org
Always discuss trial participation with your own doctor first.
| Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities) | Basking Ridge, New Jersey, United States | Recruiting |
| Memorial Sloan Kettering at Monmouth (Limited Protocol Activities) | Middletown, New Jersey, United States | Recruiting |
| Memorial Sloan Kettering at Bergen (Limited Protocol Activities) | Montvale, New Jersey, United States | Recruiting |
| Memorial Sloan Kettering Suffolk-Commack (Limited Protocol Activities) | Commack, New York, United States | Recruiting |
| Memorial Sloan Kettering at Westchester (Limited Protocol Activities) | Harrison, New York, United States | Recruiting |
| Weill Cornell Medical Center (Data Collection Only) | New York, New York, United States | Not Yet Recruiting |
| Memorial Sloan Kettering Cancer Center (All Protocol Activites) | New York, New York, United States | Recruiting |
| Memorial Sloan Kettering at Nassau (Limited Protocol Activities) | Uniondale, New York, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07548164